Showing results (1-10 of 73) with videos related to
Sort By:
Pageof 8
Gene Therapy|June 18, 2010
Adoptive immunotherapy with genetically engineered T cells: modification of the IgG1 Fc 'spacer' domain in the extracellular moiety of chimeric antigen receptors avoids 'off-target' activation and unintended initiation of an innate immune responseA Hombach, A A Hombach, H AbkenOncoimmunology|June 27, 2013
Targeting two co-operating cytokines efficiently shapes immune responsesAndreas A Hombach, Hinrich AbkenFrontiers in Immunology|June 14, 2013
Young T Cells Age During a Redirected Anti-Tumor Attack: Chimeric Antigen Receptor-Provided Dual Costimulation is Half the BattleAndreas A Hombach, Hinrich AbkenExpert Review of Clinical Immunology|August 23, 2016
Shared target antigens on cancer cells and tissue stem cells: go or no-go for CAR T cells?Andreas A Hombach, Hinrich AbkenInternational Journal of Cancer|October 28, 2011
Costimulation by chimeric antigen receptors revisited the T cell antitumor response benefits from combined CD28-OX40 signallingAndreas A Hombach, Hinrich AbkenMethods in Molecular Biology (Clifton, N.J.)|August 22, 2012
Antibody-IL2 fusion proteins for tumor targetingAndreas A Hombach, Hinrich AbkenCancers|August 30, 2017
Most Do, but Some Do Not: CD4⁺CD25<sup>-</sup> T Cells, but Not CD4⁺CD25⁺ Treg Cells, Are Cytolytic When Redirected by a Chimeric Antigen Receptor (CAR)Andreas A Hombach, Hinrich AbkenHepato-Gastroenterology|February 26, 2000
Chronic inflammatory bowel disease and cancerC Pohl, A Hombach, W KruisGene Therapy|October 15, 2010
CD28 cosignalling does not affect the activation threshold in a chimeric antigen receptor-redirected T-cell attackM Chmielewski, A A Hombach, H AbkenPageof 8